Advertisement
Advertisement

PLUR

PLUR logo

Pluri Inc. Common Stock

3.48
USD
Sponsored
+0.15
+4.34%
May 08, 15:08 UTC -4
Closed
exchange

After-Market

3.47

-0.01
-0.43%

Pluri Inc. Common Stock Profile

About

Pluri Inc. is a biotechnology company. Its technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of medicine and climate change to food scarcity, animal cruelty and beyond. Pluri Inc., formerly known as Pluristem Therapeutics Inc., is based in HAIFA, Israel.

Info & Links

CEO

Yaky Yanay

Headquarters

MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5
HAIFA, L3 3508409, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://pluri-biotech.com

Auditor

Kesselman & Kesselman

Share holders

66

Employees

142

Pluri Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

37.39M

Enterprise Value

60.56M

Enterprise Value/EBITDA(ttm)

-2.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

18.42

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

40.92%

Operating Margin(ttm)

-1890.59%

Profit Margin(ttm)

-2126.11%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

1060.09%

Return on Assets(ttm)

-99.68%

Income Statement

Revenue(ttm)

1.34M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

544.00K

EBITDA(ttm)3

-24.43M

Net Income Available to Common(ttm)

-26.14M

Diluted EPS(ttm)

-4.92

Share Statistics

Beta (5Y Monthly)

0.72

52-Week Change

-34.15%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.05M

Dividend Yield

0.00%

Float4

7.45M

% Held by Insiders

25.93%

% Held by Institutions

16.59%

Balance Sheet

Total Cash(mrq)

12.71M

Total Cash Per Share(mrq)

1.26

Total Debt(mrq)

28.08M

Total Debt/Equity(mrq)

-304.81%

Current Ratio(mrq)

0.43%

Quick Ratio(mrq)

0.43%

Book Value Per Share(mrq)

-0.92

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.15

Free Cash Flow(ytd)

-11.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement